Abbisko Medicine CEO Xu Yao-Chang Raises Stake to 11.26%

PUBT · 1d ago
Abbisko Medicine CEO Xu Yao-Chang Raises Stake to 11.26%
  • Abbisko Medicine CEO Xu Yao-Chang purchased 145,000 ordinary shares on November 11, 2026.
  • The purchase represented approximately 0.02% of issued shares, at an average price of approximately HK$ 6.67 per share.
  • His holding rose to 81,747,574 shares, representing approximately 11.26% of issued shares.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Abbisko Medicine Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261111-12408605), on November 11, 2026, and is solely responsible for the information contained therein.